Hypoglycemia with Mealtime Fast-Acting Insulin Aspart vs. Insulin Aspart Across Two Large Type 1 Diabetes Trials

被引：10
|
作者：
De Block, Christophe
Carlson, Anders
Rose, Ludger
Gondolf, Theis
Gorst-Rasmussen, Anders
Lane, Wendy
机构：
来源：
DIABETES | 2018年 / 67卷
关键词：
D O I：
10.2337/db18-96-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The Impact of Baseline BMI and HbA1c on Glycemic Control after Treatment with Mealtime Fast-Acting Insulin Aspart in People with Type 1 Diabetes
    Russell-Jones, David
    Heller, Simon R.
    Woo, Vincent C.
    Babu, Vinay
    Dethlefsen, Claus
    Mathieu, Chantal
    DIABETES, 2017, 66 : A616 - A616
  • [42] Double-blind mealtime faster-acting insulin aspart vs insulin aspart in basal-bolus improves glycaemic control in Type 1 diabetes: the onset 1 trial
    Russell-Jones, D.
    Bode, B. W.
    De Block, C.
    Franek, E.
    Heller, S.
    Mathieu, C.
    Philis-Tsimikas, A.
    Rose, L.
    Woo, V.
    Osterskov, A. B.
    Graungaard, T.
    Bergenstal, R.
    DIABETIC MEDICINE, 2017, 34 : 8 - 8
  • [43] The value of fast-acting insulin aspart compared with insulin aspart for patients with diabetes mellitus treated with bolus insulin from a UK health care system perspective
    Leelarathna, Lalantha
    Ashley, Donna
    Fidler, Carrie
    Parekh, Witesh
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2018, 9 (07) : 187 - 197
  • [44] Elucidating the Mechanism of Absorption of Fast-Acting Insulin Aspart: The Role of Niacinamide
    Kildegaard, Jonas
    Buckley, Stephen T.
    Nielsen, Rasmus H.
    Povlsen, Gro K.
    Seested, Torben
    Ribel, Ulla
    Olsen, Helle B.
    Ludvigsen, Svend
    Jeppesen, Claus B.
    Refsgaard, Hanne H. F.
    Bendtsen, Kristian M.
    Kristensen, Niels R.
    Hostrup, Susanne
    Sturis, Jeppe
    PHARMACEUTICAL RESEARCH, 2019, 36 (03)
  • [45] A survey of physician experience and treatment satisfaction using fast-acting insulin aspart in people with type 1 or type 2 diabetes
    Baru, Ankita
    Amir, Sadaf
    Ekelund, Magnus
    Montagnoli, Roberta
    Fernandes, Joao Diogo Da Rocha
    POSTGRADUATE MEDICINE, 2020, 132 (04) : 320 - 327
  • [46] Fast-acting insulin aspart in Japanese patients with type 1 diabetes: Faster onset, higher early exposure and greater early glucose-lowering effect relative to insulin aspart
    Shiramoto, Masanari
    Nishida, Tomoyuki
    Hansen, Ann Kathrine
    Haahr, Hanne
    JOURNAL OF DIABETES INVESTIGATION, 2018, 9 (02) : 303 - 310
  • [47] Efficacy and safety of fast-acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): A 52-week, randomized, treat-to-target, phase III trial
    Mathieu, Chantal
    Bode, Bruce W.
    Franek, Edward
    Philis-Tsimikas, Athena
    Rose, Ludger
    Graungaard, Tina
    Osterskov, Anne Birk
    Russell-Jones, David
    DIABETES OBESITY & METABOLISM, 2018, 20 (05): : 1148 - 1155
  • [48] Efficacy and Safety of Fast-Acting Insulin Aspart in People with Type 1 Diabetes Using Carbohydrate Counting: A Post Hoc Analysis of Two Randomised Controlled Trials
    Rose, Ludger
    Kadowaki, Takashi
    Pieber, Thomas R.
    Buchholtz, Kristine
    Ekelund, Magnus
    Gorst-Rasmussen, Anders
    Philis-Tsimikas, Athena
    DIABETES THERAPY, 2019, 10 (03) : 1029 - 1041
  • [49] Efficacy and Safety of Fast-Acting Insulin Aspart in People with Type 1 Diabetes Using Carbohydrate Counting: A Post Hoc Analysis of Two Randomised Controlled Trials
    Ludger Rose
    Takashi Kadowaki
    Thomas R. Pieber
    Kristine Buchholtz
    Magnus Ekelund
    Anders Gorst-Rasmussen
    Athena Philis-Tsimikas
    Diabetes Therapy, 2019, 10 : 1029 - 1041
  • [50] Elucidating the Mechanism of Absorption of Fast-Acting Insulin Aspart: The Role of Niacinamide
    Jonas Kildegaard
    Stephen T. Buckley
    Rasmus H. Nielsen
    Gro K. Povlsen
    Torben Seested
    Ulla Ribel
    Helle B. Olsen
    Svend Ludvigsen
    Claus B. Jeppesen
    Hanne H. F. Refsgaard
    Kristian M. Bendtsen
    Niels R. Kristensen
    Susanne Hostrup
    Jeppe Sturis
    Pharmaceutical Research, 2019, 36
12345